Search

everythinglearnresearchcommunity

for

Search:↓

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Follicle Stimulating Hormone is important for fertility.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Advanced human skin models improve drug development and could replace animal testing.

FGF5 gene mutations cause unusually long eyelashes by affecting hair growth regulation.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Hair follicle sampling is a practical method for measuring biomarkers in children with and without Fragile X syndrome.

Hair follicle sampling is a feasible method to measure FMRP and FMR1 mRNA levels in children.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Androgens can both increase body hair and cause scalp hair loss.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.